| Primary |
| Chronic Obstructive Pulmonary Disease |
60.1% |
| Asthma |
5.6% |
| Hypertension |
5.5% |
| Off Label Use |
4.9% |
| Emphysema |
4.3% |
| Dyspnoea |
3.8% |
| Lung Disorder |
3.4% |
| Diabetes Mellitus |
2.1% |
| Cardiac Disorder |
1.6% |
| Respiratory Disorder |
1.5% |
| Bronchitis |
1.2% |
| Depression |
1.2% |
| Pneumonia |
1.0% |
| Bronchial Disorder |
0.7% |
| Cough |
0.7% |
| Blood Pressure Increased |
0.6% |
| Hypercholesterolaemia |
0.5% |
| Respiratory Failure |
0.5% |
| Arrhythmia |
0.5% |
| Atrial Fibrillation |
0.5% |
|
| Death |
27.1% |
| Dyspnoea |
8.0% |
| Pneumonia |
7.2% |
| Lung Neoplasm Malignant |
5.6% |
| Chronic Obstructive Pulmonary Disease |
4.8% |
| Cough |
4.4% |
| Arrhythmia |
4.2% |
| Myocardial Infarction |
4.0% |
| Cardiac Arrest |
3.6% |
| Malaise |
3.4% |
| Tachycardia |
3.4% |
| Lung Disorder |
3.2% |
| Respiratory Disorder |
3.0% |
| Pulmonary Oedema |
2.8% |
| Respiratory Failure |
2.8% |
| Inappropriate Schedule Of Drug Administration |
2.6% |
| Palpitations |
2.6% |
| Pyrexia |
2.6% |
| Emphysema |
2.4% |
| Fatigue |
2.4% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
31.3% |
| Asthma |
13.1% |
| Off Label Use |
12.7% |
| Dyspnoea |
6.5% |
| Emphysema |
6.5% |
| Hypertension |
5.1% |
| Lung Disorder |
4.1% |
| Respiratory Disorder |
3.8% |
| Cardiac Disorder |
2.7% |
| Cough |
1.9% |
| Respiratory Failure |
1.6% |
| Anaemia |
1.5% |
| Pneumonia |
1.5% |
| Blood Pressure |
1.2% |
| Bronchitis |
1.2% |
| Pain |
1.2% |
| Diabetes Mellitus |
1.1% |
| Prophylaxis |
1.1% |
| Blood Cholesterol |
0.9% |
| Bronchial Disorder |
0.9% |
|
| Pneumonia |
16.3% |
| Death |
9.8% |
| Inappropriate Schedule Of Drug Administration |
6.5% |
| Malaise |
6.5% |
| Cough |
5.7% |
| Dyspnoea |
5.7% |
| Haemoptysis |
4.9% |
| Myocardial Infarction |
4.9% |
| Tremor |
4.9% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Urinary Tract Infection |
4.1% |
| Pulmonary Fibrosis |
3.3% |
| Renal Disorder |
3.3% |
| Respiratory Tract Infection |
3.3% |
| Upper Limb Fracture |
3.3% |
| Weight Increased |
3.3% |
| Wrist Fracture |
3.3% |
| Asthmatic Crisis |
2.4% |
| Cerebrovascular Accident |
2.4% |
| Drug Ineffective |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.4% |
| Chronic Obstructive Pulmonary Disease |
18.9% |
| Hypertension |
9.5% |
| Cardiac Failure |
6.5% |
| Asthma |
3.6% |
| Atrial Fibrillation |
3.3% |
| Colitis Ulcerative |
2.4% |
| Lung Neoplasm Malignant |
2.4% |
| Chemotherapy |
2.1% |
| Diabetes Mellitus |
2.1% |
| Dyspnoea |
2.1% |
| Pain |
2.1% |
| Emphysema |
1.8% |
| Psoriatic Arthropathy |
1.8% |
| Cardiac Failure Chronic |
1.5% |
| Crohn's Disease |
1.5% |
| Malignant Breast Neoplasm |
1.5% |
| Pulmonary Hypertension |
1.5% |
| Cardiovascular Event Prophylaxis |
1.2% |
| Depression |
1.2% |
|
| Death |
8.1% |
| Haemangioma Of Skin |
8.1% |
| Hypertension |
8.1% |
| Pneumonia |
8.1% |
| Cholestasis |
5.4% |
| Dyspnoea |
5.4% |
| Lung Neoplasm Malignant |
5.4% |
| Overdose |
5.4% |
| Pain |
5.4% |
| Pulmonary Embolism |
5.4% |
| Urinary Retention |
5.4% |
| Weight Increased |
5.4% |
| Wrong Technique In Drug Usage Process |
5.4% |
| Anaemia |
2.7% |
| Anaphylactic Shock |
2.7% |
| Aortic Aneurysm Rupture |
2.7% |
| Aspartate Aminotransferase Increased |
2.7% |
| Atrioventricular Block First Degree |
2.7% |
| Blood Alkaline Phosphatase Increased |
2.7% |
| Bradycardia |
2.7% |
|
| Interacting |
| Cardiac Failure |
18.2% |
| Hepatic Cirrhosis |
18.2% |
| Hypertension |
18.2% |
| Type 2 Diabetes Mellitus |
18.2% |
| Dyslipidaemia |
9.1% |
| Dyslipidemia |
9.1% |
| Respiratory Disorder |
9.1% |
|
| Ventricular Extrasystoles |
100.0% |
|
